Multiple Sclerosis Clinical Trials in Los Angeles

Showing 361-380 of 489 trials

COMPLETEDPhase 1< 1 mile

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

NCT02081495

The purpose of this study is to support the qualification of a replacement manufacturing site for DOXIL/CAELYX.

Neoplasms

Janssen Research & Development, LLC35 participantsStarted Aug 2014

Los Angeles, California, United States • Brussels, Belgium • Wilrijk, Belgium +3 more locations

COMPLETEDPhase 2< 1 mile

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

NCT00524303

This study will examine safety and efficacy of Lapatinib in combination with a standard neoadjuvant chemotherapy including 5FU, Epirubicin, Cyclophosphamide and Paclitaxel. Tumor tissue will be obtained at 3 timepoints (optional 4th) to evaluate tumor response to treatment.

Neoplasms, Breast

GlaxoSmithKline100 participantsStarted Aug 2007

Fountain Valley, California, United States • Los Angeles, California, United States • Denver, Colorado, United States +20 more locations

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.

Multiple Sclerosis Trials in Other Cities

Safety, Tolerability, and Pharmacokinetics of Onartuzumab Combined With Vemurafenib and/or Cobimetinib in Cancer Patients

JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab

Locomotor Training in Persons With Multiple Sclerosis

Gene Expression Profiles to Categorize Wilms Tumors

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

EPO906 Therapy in Patients With Prostate Cancer

Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer

Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial Carcinoma

Efficacy and Safety of GTR in Comparison to Copaxone®

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis

BIBW 2992 (Afatinib) in Head & Neck Cancer

A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf)

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study

Real-world Outcomes on Tecfidera (BG00012, Dimethyl Fumarate) Post-Tysabri (BG00002, Natalizumab)

JC-Virus (JCV) Antibody Program

Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients

Other Conditions in Los Angeles